The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectris Regulatory News (SXS)

Share Price Information for Spectris (SXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,302.00
Bid: 3,304.00
Ask: 3,312.00
Change: 6.00 (0.18%)
Spread: 8.00 (0.242%)
Open: 3,376.00
High: 3,376.00
Low: 3,286.00
Prev. Close: 3,296.00
SXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Director

24 Aug 2023 07:00

RNS Number : 2513K
Spectris PLC
24 August 2023
 

Spectris plc

Directorate change

 

directorate change

Spectris plc ('Spectris') (LSE: SXS), the expert in providing insight through precision measurement, today announces that Mandy Gradden has been appointed to its Board as a Non-Executive Director with effect from 16 October 2023.

 

MANDY GRADDEN

Mandy is Chief Financial Officer ('CFO') of Ascential plc and brings to the Board significant experience in finance, investor relations, strategy, digital and software.

Before joining Ascential in 2013, Mandy held a variety of financial roles, including CFO at the FTSE 250 technology business, Detica Group plc, CFO at Torex, the private equity owned retail technology firm, Director of Corporate Development at Telewest and Group Financial Controller at Dalgety plc. She began her career at Price Waterhouse, where she spent eight years and where she qualified as a chartered accountant.

In addition to her executive career, Mandy was previously a Non-Executive Director and Chair of the Audit Committee at SDL plc and is Chair of the UK Financial Conduct Authority's Listing Authority Advisory Panel.

 

Through the search process, the Nomination & Governance Committee considered the composition of the Board as a whole, taking into account the balance of diversity, ethnicity, skills, experience and knowledge, as well as the tenure and independence of all Board members.

 

Announcing the appointment, Mark Williamson, Chairman, said: "I am delighted that Mandy has agreed to join the Board. She will bring a broad range of relevant and current experience to the Board, alongside her significant knowledge of the current financial and reporting landscape and I look forward to welcoming her to the Board."

 

Mandy will join the Audit & Risk Committee and the Nomination & Governance Committee on appointment to the Board.

 

There are no further details to be disclosed in respect of Listing Rule 9.6.13.

 

 

Contacts:

 

Mat Wootton

Director of Investor Relations

+44 1784 485325/+44 7500 078880

 

Rebecca Dunn

Company Secretary and Head of Corporate Affairs

+44 7 464 677320

 

LEI Number: 213800Z4CO2CZO3M3T10

 

 

About Spectris

 

Spectris combines precision with purpose, delivering progress for a more sustainable world. We provide critical insights to our customers through premium precision measurement solutions combined with technical expertise and deep domain knowledge. Precision is at the heart of what we do - our leading, high-tech instruments and software equip our customers to solve some of their greatest challenges to make the world cleaner, healthier and more productive. We are focused on two key Divisions - Spectris Scientific and Spectris Dynamics, which are placed in technology-driven end markets, with strong fundamentals and attractive growth trajectories. We have leading market positions in premium segments and employ 7,300 people located in more than 30 countries, all united behind our purpose to deliver value beyond measure for all our stakeholders. For more information, visit www.spectris.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPJMITMTITBMJ
Date   Source Headline
4th May 20237:00 amRNSTransaction in Own Shares
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 202312:00 pmRNSTotal Voting Rights
2nd May 20237:00 amRNSTransaction in Own Shares
28th Apr 20237:00 amRNSTransaction in Own Shares
27th Apr 20237:00 amRNSQ1 Trading update
27th Apr 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20235:58 pmRNSTransaction in Own Shares
19th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20236:28 pmRNSTransaction in Own Shares
17th Apr 20237:26 amRNSTransaction in Own Shares
13th Apr 20236:09 pmRNSTransaction in Own Shares
12th Apr 20235:57 pmRNSTransaction in Own Shares
12th Apr 20233:50 pmRNSDirector/PDMR Shareholding
12th Apr 20237:00 amRNSTransaction in Own Shares
11th Apr 20237:00 amRNSTransaction in Own Shares
6th Apr 20237:00 amRNSTransaction in Own Shares
5th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 20236:14 pmRNSTransaction in Own Shares
3rd Apr 202310:30 amRNSTotal Voting Rights
3rd Apr 20237:00 amRNSTransaction in Own Shares
31st Mar 20237:00 amRNSTransaction in Own Shares
30th Mar 20233:01 pmRNSDirector/PDMR Shareholding
29th Mar 20236:12 pmRNSTransaction in Own Shares
29th Mar 20237:00 amRNSTransaction in Own Shares
27th Mar 20236:28 pmRNSTransaction in Own Shares
27th Mar 202310:06 amRNSAnnual Financial Report
27th Mar 20237:00 amRNSTransaction in Own Shares
23rd Mar 20236:19 pmRNSTransaction in Own Shares
23rd Mar 20237:00 amRNSTransaction in Own Shares
22nd Mar 20237:00 amRNSTransaction in Own Shares
21st Mar 20237:00 amRNSTransaction in Own Shares
20th Mar 20237:00 amRNSShare buyback programme
8th Mar 20235:07 pmRNSDirector/PDMR Shareholding
1st Mar 202312:21 pmRNSTotal Voting Rights
23rd Feb 20237:00 amRNS2022 full year results
8th Feb 20236:17 pmRNSDirector/PDMR Shareholding
1st Feb 202312:31 pmRNSTotal Voting Rights
10th Jan 20232:54 pmRNSDirector/PDMR Shareholding
3rd Jan 202311:48 amRNSTotal Voting Rights
20th Dec 20224:46 pmRNSTotal Voting Rights
19th Dec 20227:00 amRNSTransaction in Own Shares
16th Dec 20227:00 amRNSTransaction in Own Shares
14th Dec 20225:58 pmRNSTransaction in Own Shares
14th Dec 20227:00 amRNSTransaction in Own Shares
13th Dec 20223:28 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.